← Leaderboards
Mary Ann Y Jabra-Rizk
University Of Maryland Baltimore
$6,145,608
Attributed
$6,946,995
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $854.9K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,946,995 · 8
By mechanism
R01$4,492,406 · 3
S10$854,915 · 1
R21$849,750 · 2
K22$601,424 · 1
R03$148,500 · 1
Top collaborators
- Shyam Biswal3 shared
- Claire M Fraser-Liggett3 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- John T McDevitt$21,567,166
Others in their field
Top investigators on “Candida Albicans”
- Alexander D Johnson · University Of California San Francisco$23,545,370
- Aaron P Mitchell · La Biomed Res Inst/ Harbor Ucla Med Ctr$20,872,115
- Gavin J Sherlock · Stanford University$18,218,461
- Jay B Jackson · Johns Hopkins University$17,529,470
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$14,524,347
- Gerald R Fink · Whitehead Institute For Biomedical Res$14,278,186
Research focus
Candida AlbicansLeadTissuesInfectionIn VivoIn VitroMouse ModelVirulenceOralMicrobial BiofilmsDesignChronicCandidiasisInvestigationComplexCandidaMicrobialMorbidity - Disease RateBaseAnimal ModelSurfacePrevalenceOral Mucous Membrane StructureSite
Grant awards (25)
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections$193,125
R21 · FY2023 · DE · contact PI
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections$231,750
R21 · FY2022 · DE · contact PI
"Acquisition of a Multi-functional Cryo Scanning Electron Microscope (SEM)"$854,915
S10 · FY2021 · OD · contact PI
C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy$335,081
R01 · FY2020 · AI · contact PI
Candida-Associated Denture Stomatitis: A Novel Preventative Approach in an Experimental Aging Rat Model of Oral Infection$193,125
R21 · FY2020 · DE · contact PI
C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy$355,471
R01 · FY2019 · AI · contact PI
Candida-Associated Denture Stomatitis: A Novel Preventative Approach in an Experimental Aging Rat Model of Oral Infection$231,750
R21 · FY2019 · DE · contact PI
E-Cigarette use as a Modifier of Oral Host Defense and Microbiome in Young Adults$395,482
R01 · FY2018 · DE
C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy$374,794
R01 · FY2018 · AI · contact PI
E-Cigarette use as a Modifier of Oral Host Defense and Microbiome in Young Adults$395,623
R01 · FY2017 · DE
C. albicans and S. aureus Catheter Infections: Clinical Implications and Therapy$387,330
R01 · FY2017 · AI · contact PI
E-Cigarette use as a Modifier of Oral Host Defense and Microbiome in Young Adults$410,975
R01 · FY2016 · DE
Candida albicans and Staphylococcus aureus dual species biofilms$371,250
R01 · FY2014 · DE · contact PI
Candida albicans and Staphylococcus aureus dual species biofilms$356,400
R01 · FY2013 · DE · contact PI
Candida albicans and Staphylococcus aureus dual species biofilms$371,250
R01 · FY2012 · DE · contact PI
Candida albicans and Staphylococcus aureus dual species biofilms$363,750
R01 · FY2011 · DE · contact PI
Candida albicans and Staphylococcus aureus dual species biofilms$375,000
R01 · FY2010 · DE · contact PI
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$134,584
K22 · FY2006 · DE · contact PI
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$134,584
K22 · FY2005 · DE
Receptor Affects Fungal Mucosal Colonization in HIV$74,250
R03 · FY2005 · DE
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$134,584
K22 · FY2004 · DE
Receptor Affects Fungal Mucosal Colonization in HIV$74,250
R03 · FY2004 · DE
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$864
K22 · FY2004 · DE
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$101,212
K22 · FY2003 · DE
MOLECULAR BASIS OF VIRULENCE FACTORS OF ORAL FUNGAL SP.$95,596
K22 · FY2002 · DE